Zimmer Biomet (NYSE:ZBH) said last week that it closed its acquisition of Compression Therapy Products for an undisclosed amount.
Eatontown, N.J.-based CTC makes non-invasive devices designed to prevent deep-vein thrombosis. The devices use CTC’s VasoPress system to compress the foot, calf and thigh to lower the risk of pulmonary embolism, according to the company’s website.
In a regulatory filing, Zimmer Biomet said it will operate the business as a wholly owned subsidiary.
Earlier this month, the Warsaw, Ind.-based orthopedics giant agreed to put up roughly $1 billion for spinal implant maker LDR Holding, in a $37-per-share deal that’s expected to close during the 3rd quarter.
The post Zimmer Biomet acquires Compression Therapy Concepts appeared first on MassDevice.